NCT01712659 2023-01-10Ruxolitinib for Adult T-Cell LeukemiaNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated19 enrolled 17 charts
NCT00001941 2012-08-20Anti-Tac for Treatment of LeukemiaNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed34 enrolled 12 charts